Table F-46Depression symptom reduction (any measure) for SSRIs compared with placebo: Statistics with one study removed, by drug

Study OmittedOverall Estimate95% Confidence Interval
Fluoxetine
Martenyi, 2007 (20mg)−0.21(−0.50 to −0.09)
Martenyi, 2007 (40mg)−0.21(−0.50 to −0.09)
Martenyi, 2002−0.12(−0.29 to −0.06)
van der Kolk, 2007−0.25(−0.44 to −0.06)
Combined−0.20(−0.40 to −0.00)
Paroxetine
Marshall, 2001 (20mg)−0.43(−0.61 to −0.25)
Marshall, 2001 (40mg)−0.47(−0.72 to −0.22)
Tucker, 2001−0.56(−0.70 to −0.41)
Combined−0.49(−0.64 to −0.34)
Sertraline
Brady, 2005−0.16(−0.37 to 0.05)
Brady, 2000−0.10(−0.32 to 0.12)
Davidson, 2006−0.15(−0.40 to 0.11)
Davidson, 2001−0.14(−0.38 to 0.10)
Friedman, 2007−0.19(−0.38 to 0.00)
Tucker, 2004−0.15(−0.35 to 0.05)
Zohar, 2002−0.09(−0.22 to 0.04)
Combined−0.13(−0.32 to 0.06)

From: Appendix F, Meta-Analysis

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) [Internet].
Comparative Effectiveness Reviews, No. 92.
Jonas DE, Cusack K, Forneris CA, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.